EB

Ejaz Bidiwala Asraf

Active Director Additional Director DIN 07773261
DIN 07773261 First appointment Mar 2017 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Ejaz Bidiwala Asraf

Data last updated:

Ejaz Bidiwala Asraf is an Additional Director at International Pulmonary Care Private Limited (since 2017). The company operates in Healthcare.

DIN 07773261
Primary Designation Additional Director
Industry Healthcare
First Appointment 22 Mar 2017
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director22 Mar 20172016Active

Board colleagues of Ejaz Bidiwala Asraf

NameDINCompanyDesignation
Hema Maisuria07387350International Pulmonary Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
International Pulmonary Care Private Limited
Premium access

Shareholding and investment profile for Ejaz Bidiwala Asraf

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ejaz Bidiwala Asraf

Ejaz Bidiwala Asraf currently holds 1 directorship: International Pulmonary Care Private Limited (Additional Director, since 22 Mar 2017).

Ejaz Bidiwala Asraf was first appointed on 22 Mar 2017 as Additional Director at International Pulmonary Care Private Limited.

The current boards of Ejaz Bidiwala Asraf's companies include Hema Maisuria (International Pulmonary Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available